Skip to content

Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer

Clinical Utility and Initial Experience With PEM Flex Solo II PET Scanner and Stereo Navigator Biopsy Accessory for the Diagnosis of Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00981812
Enrollment
20
Registered
2009-09-22
Start date
2009-09-30
Completion date
2012-04-30
Last updated
2016-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

PET, PEM, Positron Emission Mammography, Breast Biopsy

Brief summary

The purpose of this research study is to evaluate how well the Stereo Navigator Biopsy Accessory for the PEM Flex solo II PET Scanner works for performing breast biopsy on suspicious lesions. This study will also allow the doctors to describe the features of PEM detected lesions and the results obtained using the PEM guided biopsy and will compare the time it took to complete a pre-operative work up using PEM versus MRI in patients with a suspicious breast lesion resulting in cancer.

Detailed description

See brief summary.

Interventions

PROCEDUREPEM Breast Biopsy

Breast biopsy using PEM guidance and Stereo Navigator software

Sponsors

University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* female * subject is 25-100 years of age * subjects has at least one breast imaging finding on mammography and/or ultrasound which is assessed as highly suggestive of malignancy and recommended to biopsy * subject is able to provide informed consent

Exclusion criteria

* subject is pregnant * subject is actively lactating or discontinued breastfeeding less than 2 months ago * subject has breast implants * subject is scheduled for sentinel node procedure using radioactive Tc-99m within 24 hours of the PEM study * subject has contraindications for core biopsy and other invasive procedures * subject has Type I diabetes mellitus or poorly controlled Type II diabetes mellitus * subject has had surgery or radiation therapy on the study breast or has had chemotherapy within the past 12 months * subject has not fasted for 4-6 hours prior to the procedure and/or have a fasting blood glucose level greater than 140 mg/dl on day of PEM imaging

Design outcomes

Primary

MeasureTime frame
Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.At time of biopsy

Countries

United States

Participant flow

Recruitment details

Recruited from 02/2010 to 06/2011 from University of Cincinnati Medical Center, Radiology Department, Breast Imaging.

Participants by arm

ArmCount
Primary
Women 25 years or older with a highly suspicious finding for possible breast cancer on mammography and/or ultrasound, who are to be scheduled for percutaneous breast biopsy.
20
Total20

Baseline characteristics

CharacteristicPrimary
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
17 Participants
Sex: Female, Male
Female
20 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.

Time frame: At time of biopsy

ArmMeasureGroupValue (NUMBER)
Lesions Visualized Using Positron Emission Mammography (PEM)Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.Index Lesioins22 Breast Lesions
Lesions Visualized Using Positron Emission Mammography (PEM)Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.Index Lesions Visualized at PEM21 Breast Lesions
Lesions Visualized Using Positron Emission Mammography (PEM)Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.Additional Lesions seen only at PEM6 Breast Lesions
Lesions Visualized Using Positron Emission Mammography (PEM)Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.Lesions technically adequate for targeting26 Breast Lesions
Lesions Visualized Using Positron Emission Mammography (PEM)Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.Number of Lesions Biopsied24 Breast Lesions

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026